Malin Corporation | MLC - Equity Capital And Reserves


Malin Corporation reported EUR193.2M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 41.59M 12.37M Sep/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
ALKERMES USD 1.73B 108.85M Sep/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Eurofins Scientific SE EUR 3.54B 114.8M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Lonza CHF 9.33B 23M Dec/2024
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Ovoca Bio EUR 8.67M 4.76M Jun/2022
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025